Neurelis logo

Neurelis Funding & Investors

Neurelis Inc., is a pharmaceutical company. The Company develops and commercializes product candidates for the treatment of central nervous system disorders, acute epilepsy, and anxiety episodes.

neurelis.com

Total Amount Raised: $206,081,952

Neurelis Funding Rounds

  • Series D

    $114,000,000

    Series D Investors

    HBM Healthcare Investments
    Cormorant Asset Management
    Decheng Capital
    LYZZ Capital
    Philos & Partners
  • Series Unknown

    $40,500,000

  • Debt Financing

    $5,200,000

  • Series B

    $42,098,000

    Series B Investors

    HBM Healthcare Investments
    LYZZ Capital
  • Series Unknown

    $1,500,000

  • Debt Financing

    $1,083,950

  • Debt Financing

    $1,700,000

Funding info provided by Diffbot.